| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000767993 |
| P356 | DOI | 10.1038/LABINVEST.3780192 |
| P698 | PubMed publication ID | 11140694 |
| P50 | author | Helmut Friess | Q15453363 |
| P2093 | author name string | Reubi JC | |
| Fleischmann A | |||
| Buechler MW | |||
| Läderach U | |||
| P2860 | cites work | Neurons containing gastrin releasing peptide-like immunoreactivity in the human pancreas | Q72904692 |
| Yttrium-90-labelled somatostatin-analogue for cancer treatment | Q74242385 | ||
| Expression of somatostatin receptors in peritumoral veins of human tumors | Q77916786 | ||
| Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis | Q24514794 | ||
| Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
| Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4) | Q34202759 | ||
| Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma | Q35350126 | ||
| In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues | Q35904689 | ||
| Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas | Q36421669 | ||
| Progress in the development of potent bombesin receptor antagonists | Q36634762 | ||
| Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells | Q37596920 | ||
| Discovery, isolation, and characterization of bombesin-like peptides | Q39569850 | ||
| Mammalian bombesin receptors | Q40928891 | ||
| The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract | Q41136904 | ||
| Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer | Q41362569 | ||
| Cloning and Functional Characterization of a Complementary DNA Encoding the Murine Fibroblast Bombesin/Gastrin-Releasing Peptide Receptor | Q41713658 | ||
| Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast | Q42795202 | ||
| Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes | Q42830633 | ||
| Influence of bombesin on gastrointestinal and pancreatic cell growth in adult and suckling animals | Q44241275 | ||
| Alterations in receptors for sensory neuropeptides in human inflammatory bowel disease. | Q45002894 | ||
| Localization of specific binding sites for bombesin in the canine gastrointestinal tract | Q46444922 | ||
| Neuronal gastrin-releasing peptide in the mammalian gut and pancreas. | Q53919815 | ||
| Changes in peptidergic innervation in chronic pancreatitis | Q67533543 | ||
| Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking | Q67687445 | ||
| Analysis of nerves in chronic pancreatitis | Q68326119 | ||
| Mechanisms of the trophic actions of bombesin on the pancreas | Q69028286 | ||
| Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis | Q69696757 | ||
| Differential effects of experimentally induced chronic pancreatitis on neuropeptide immunoreactivities in the feline pancreas | Q71601804 | ||
| Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas | Q71797622 | ||
| Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway | Q71838661 | ||
| Substance-P receptors in human primary neoplasms: tumoral and vascular localization | Q72333403 | ||
| Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors | Q72741141 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1807-1817 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Bombesin receptors in distinct tissue compartments of human pancreatic diseases | |
| P478 | volume | 80 |
| Q37286800 | 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor |
| Q39435556 | A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation |
| Q33637115 | Bombesin receptor subtype 3 as a potential target for obesity and diabetes |
| Q40177476 | DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours |
| Q37137779 | Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector |
| Q93010960 | Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors |
| Q39666421 | Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours |
| Q35846757 | Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer. |
| Q47771370 | Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue |
| Q40299170 | Enzyme-based visualization of receptor-ligand binding in tissues |
| Q35587983 | Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis |
| Q41353266 | Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis |
| Q40651404 | Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3. |
| Q60727900 | Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies |
| Q51813912 | Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog. |
| Q24643524 | International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states |
| Q64072212 | Localization of Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses |
| Q35417648 | ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth. |
| Q34823410 | Molecular magnetic resonance contrast agents for the detection of cancer: past and present |
| Q42876685 | Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model |
| Q42358803 | Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients |
| Q35154092 | Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs. |
| Q34001098 | Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells |
| Q53605296 | Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA. |
| Q38090926 | Targeting GRPR in urological cancers--from basic research to clinical application |
| Q36066441 | The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutrition |
Search more.